This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Michael Nedved: Innovator in Anti-TNF Antibody Manufacturing
Introduction
Michael Nedved is a notable inventor based in Downingtown, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of manufacturing methods for anti-TNF antibodies. With a total of 3 patents to his name, Nedved's work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Nedved's latest patents include innovative methods for producing anti-TNF antibody compositions. One of his patents focuses on manufacturing methods for producing a recombinant anti-TNF antibody that includes a heavy chain (HC) with amino acid sequence SEQ ID NO:36 and a light chain (LC) with amino acid sequence SEQ ID NO:37. This invention aims to enhance the efficiency of producing these critical antibodies. Another patent presents methods for producing a recombinant anti-TNF antibody with a heavy chain comprising SEQ ID NO:38 and the same light chain, further contributing to the field of antibody therapies.
Career Highlights
Michael Nedved is currently employed at Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work at this leading biotechnology company allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.
Collaborations
Some of his notable coworkers include Kristopher Barnthouse and Subinay Ganguly. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion
Michael Nedved is a prominent inventor whose work in anti-TNF antibody manufacturing is paving the way for advancements in therapeutic treatments. His contributions to biotechnology are significant and continue to influence the industry positively.